New drug boosts disease-free survival in NSCLC
May represent a treatment shift to earlier use of targeted therapy against EGFR cancer CANCER DIGEST – Feb. 11, 2023 – Non-small cell...
Drug for rare lung cancer receives FDA approval
CANCER DIGEST – Jan. 7, 2023 – The US FDA has approved a new treatment for a rare type of lung cancer following a clinical trial led by...
New immunotherapy approach promises to improve cancer outcomes
CANCER DIGEST – Nov. 19, 2022 – Researchers at Albert Einstein College of Medicine have identified an additional protein cancer cells use...
CT screening for early lung cancer leads to long-term survival
CANCER DIGEST – Nov. 27, 2022 – A new study shows that early detection of lung cancer with CT scanning dramatically increases long-term...
